Market Narratives
Market themes driving price action · Updated Apr 12, 2026
Scotiabank Raises Price Target for Federal Realty Investment Trust
An article belongs to this narrative if it discusses Scotiabank's price target change for Federal Realty Investment Trust.
Healthcare services stocks decline on moving average breaches
An article belongs to this narrative if it discusses declines in healthcare services stocks due to moving average breaches.
HPE Analysts Stay Neutral After Earnings
An article belongs to this narrative if it discusses analysts' neutral stance on Hewlett Packard Enterprise Company (HPE) following its earnings report.
SGL Carbon Q4 earnings
An article belongs to this narrative if it discusses SGL Carbon's Q4 earnings results.
CEG chosen as preferred energy source for Nissan Stadium
An article belongs to this narrative if it discusses Constellation Energy's selection as the preferred energy source for Nissan Stadium.
HON bullish sentiment despite valuation concerns
An article belongs to this narrative if it mentions Honeywell International's bullish analyst ratings despite valuation concerns.
Gen Z financial behavior shift towards crypto and sports betting
An article belongs to this narrative if it explores the trend of Gen Z turning to crypto and sports betting due to feeling financially behind.
UNP gains analyst upgrade
An article belongs to this narrative if it discusses Union Pacific Corporation's analyst upgrade.
TransAlta CEO transition and growth bets
An article belongs to this narrative if it covers TransAlta's CEO transition and its growth plans in specific regions and sectors.
META delays Avocado AI rollout
An article belongs to this narrative if it discusses Meta Platforms' delay in launching its new foundational AI model, Avocado.
BlackRock crypto business revenue
An article belongs to this narrative if it discusses BlackRock's cryptocurrency business revenue.
Income tiers defined: middle and upper brackets
An article belongs to this narrative if it discusses the definition of income tiers for middle and upper income brackets.
Ad-supported media struggles with revenue growth
An article belongs to this narrative if it discusses the challenges faced by ad-supported media platforms in generating revenue.
SNA on mechanics' uncertainty and tool purchases
An article belongs to this narrative if it discusses Snap-on's (SNA) observations on mechanics' uncertainty and their impact on tool purchases.
BSX EKOS System Successful Intermediate-Risk PE Treatment Trial
An article belongs to this narrative if it discusses Boston Scientific's EKOS Endovascular System trial results for treating intermediate-risk pulmonary embolism.
JNJ ICOTYDE Shows Promise In Plaque Psoriasis Treatment
An article belongs to this narrative if it covers Johnson & Johnson's ICOTYDE (icotrokinra) in treating moderate-to-severe plaque psoriasis.
KB Financial reports robust FY2025 performance
An article belongs to this narrative if it discusses KB Financial's FY2025 financial results.
SLF 2025 results and US dental reset
An article belongs to this narrative if it covers Sun Life Financial's 2025 results and its plans for the US dental business.
UFO sightings and nuclear missile incidents
An article belongs to this narrative if it discusses UFO sightings and their alleged impact on nuclear missiles.
SNY positive Phase 3 results for amlitelimab
An article belongs to this narrative if it discusses Sanofi's Phase 3 trial results for amlitelimab.
LXP Industrial Trust Institutional Investor Activity
An article belongs to this narrative if it reports on institutional investors buying or selling LXP Industrial Trust shares.
Sanofi Amlelimab Phase 3 Success
An article belongs to this narrative if it discusses Sanofi's Amlelimab Phase 3 trial results.
LXP Industrial Trust significant share dump by pension fund
An article belongs to this narrative if it discusses a major share sale by a pension fund in LXP Industrial Trust.
CMA orders UK vets to cap prescription fees at £21
An article belongs to this narrative if it discusses the Competition and Markets Authority's (CMA) order for UK vets to cap prescription fees.